Cardiovascular Benefits of Obesity Medication

In this penultimate episode of the video series that I recorded with ExchangeCME, I connect with Dr. Benjamin Scirica to explore the complex intersection of obesity and cardiovascular disease, with a focus on heart failure with preserved ejection fraction (HFpEF). Together, we examine the diagnostic challenges unique to patients with obesity, discuss the pathophysiologic drivers linking excess adiposity to cardiometabolic dysfunction, and review how glucagon-like peptide-1 (GLP-1) receptor agonists can be used to improve outcomes. https://bit.ly/PhoneAFriendEp9

About This Series:

In this educational video series Dr. Charles Vega and I collaborated and focused on obesity management in the GLP-1 receptor agonist era. Throughout the series, we explore common clinical challenges encountered in primary care and share practical, evidence-based approaches with insights from nationally recognized experts in obesity medicine. In this episode, I lead the discussion, and I encourage you to explore the other episodes in the series featuring Dr. Vega and additional experts in obesity medicine.

#Obesity #ObesityManagement #physician

GLP-1 - RAs and Bariatric Surgery

As the landscape of obesity treatment evolves, the intersection of pharmacologic therapies and surgical options becomes increasingly nuanced. In this episode, Dr. Janey Pratt and I explore when and how glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) can be used in relation to bariatric surgery. We discuss surgical candidacy criteria, benefits of bariatric surgery, long-term outcomes, and how to match treatment strategies to patient-specific characteristics, preferences, and goals.

This is the third of five posts highlighting the educational video series that Dr. Charles Vega and I collaborated on, focused on obesity management in the GLP-1 receptor agonist era. Throughout the series, we explore common clinical challenges encountered in primary care and share practical, evidence-based approaches with insights from nationally recognized experts in obesity medicine. In this episode, I have the opportunity to lead the discussion, and I encourage you to explore the other episodes in the series featuring Dr. Vega and additional experts in obesity medicine. https://bit.ly/3UuvyTu

#obesity #obesitymanagement #surgery #GLP1

Discussing Obesity & Obesity Medication with Patients

Dr. Charles Vega and I collaborated on a 10-part educational video series focused on obesity management in the GLP-1 receptor agonist era. The series explores common clinical challenges encountered in primary care, with discussions led by leading experts in obesity medicine. I host several episodes and will be sharing them over the coming weeks.

Episode 2 summary: Patients with obesity experience significant stigmas that often play a role in their decisions on how to manage their condition. In this episode, Dr. Fatima Cody Stanford and I discuss strategies on how to converse with a patient about their obesity, including the established benefits and adverse effects of using obesity medications, in a non-stigmatizing manner. We also review tips for educating the patient on proper self-administration of injectable obesity medication. Learn how you can apply these valuable strategies to effectively aid patients with their obesity management.

#obesity #GLP-1 #weightloss

https://youtu.be/NlVGAPZi1eM?si=ReYrROxImKebu6Mi